BRIEF-Entrada Therapeutics Inc On Track To Report Elevate-44-201 Cohort 1 Data In Q2 2026, Cohort 2 Data By End Of Year
Reuters
Feb 17
BRIEF-Entrada Therapeutics Inc On Track To Report Elevate-44-201 Cohort 1 Data In Q2 2026, Cohort 2 Data By End Of Year
Feb 17 (Reuters) - Entrada Therapeutics Inc TRDA.O:
ENTRADA THERAPEUTICS INC - ON TRACK TO REPORT ELEVATE-44-201 COHORT 1 DATA IN Q2 2026, COHORT 2 DATA BY END OF YEAR
ENTRADA THERAPEUTICS INC - INTENDS TO OPEN EXPANSION COHORT LATER THIS YEAR IN ELEVATE-44-201 STUDY
Source text: ID:nGNX25yJ7q
Further company coverage: TRDA.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.